Abstract
Background
The measurement of total and free cortisol has been studied as a clinical index of adrenal cortisol production in patients with liver cirrhosis. Correlations between free plasma and salivary cortisol have previously been reported in stable cirrhotic patients. Urinary free cortisol constitutes an index of adrenal cortisol production; however, it has never been used in assessing adrenal function in patients with liver cirrhosis.
Aims
The aim of this observational study was to determine associations between urinary free cortisol, serum total, salivary, measured and calculated plasma free cortisol levels in cirrhotics, determining which of them can be used as an indirect index of free cortisol levels. Moreover, we investigated the potential use of 24 h urinary free cortisol as a prognostic factor for mortality.
Methods
Seventy-eight outpatients with liver cirrhosis were included. Serum, salivary and urinary free cortisol were measured using the electrochemiluminenscence immunoassay. Plasma free cortisol determination was conducted using a single quadrupole mass spectrometer. The quantification of free cortisol was achieved by determining the signal response on negative ESI-MS mode.
Results
Twenty-four hour urinary free cortisol levels correlated with free cortisol determined by mass spectrometer, total cortisol and calculated free cortisol levels. Patients with low levels of urinary free cortisol presented a significantly higher mortality rate compared to those with high levels. The factors associated with death risk were determined by Cox regression. In the multivariate analysis, two models were applied; in the first model, CP score, PVT and urinary free cortisol were found to be significantly related to patients’ survival, whereas in the second, MELD score, ascites and urinary free cortisol were independently related to survival.
Conclusions
This study suggests that 24 h urinary free cortisol could be considered as a potential index of adrenal cortisol production in patients with liver cirrhosis and it potentially detects patients with a high mortality risk.
Similar content being viewed by others
References
L. Thau, J. Gandhi, S. Sharma, Physiology, Cortisol In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing, (2022)
R.H. Oakley, J.A. Cidlowski, The biology of the glucocorticoid receptor: new signaling mechanisms in health and disease. J. Allergy Clin. Immunol. 132, 1033–1044 (2013)
D.C. Aron, Basic and Clinical Endocrinology. F.S.A.G.D.G. Greenspan (Ed.), Glucocorticoids and Adrenal Androgens, Vol. 6, New York: Lange Medical Books/McGraw-Hill (2001), pp. 334–376
R.R. Singh, R. Walia, N. Sachdeva et al. Relative adrenal insufficiency in cirrhotic patients with ascites (hepatoadrenal syndrome). Dig. Liver Dis. 50, 1232–1237 (2018)
A. Pazderska, S.H. Pearce, Adrenal insufficiency–recognition and management. Clin. Med. 17, 258 (2017)
J.S. Davidson, M.J. Bolland, M.S. Croxson et al. A case of low cortisol-binding globulin: use of plasma free cortisol in interpretation of hypothalamic-pituitary-adrenal axis tests. Ann. Clin. Biochem. 43, 237–239 (2006)
U. Mueller, J.M. Potter, Binding of cortisol to human albumin and serum: the effect of protein concentration. Biochem. Pharm. 30, 727–733 (1981)
J.F. Dunn, B.C. Nisula, D. Rodbard, Transport of steroid hormones: binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasma. J. Clin. Endocrinol. Metab. 53, 58–68 (1981)
R. Ekins, Measurement of free hormones in blood. Endocr. Rev. 11, 5–46 (1990)
C.M. Mendel, M.B. Miller, P.K. Siiteri et al. Rates of dissociation of steroid and thyroid hormones from human serum albumin. J. Steroid Biochem. Mol. Biol. 37, 245–250 (1990)
R.P. Dellinger, M.M. Levy, J.M. Carlet et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit. Care Med. 36, 296–327 (2008)
P.E. Marik, S.M. Pastores, D. Annane et al. Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine. Crit. Care Med. 36, 1937–1949 (2008)
S. Tunn, H. Möllmann, J. Barth et al. Simultaneous measurement of cortisol in serum and saliva after different forms of cortisol administration. Clin. Chem. 38, 1491–1494 (1992)
U. Teruhisa, H. Ryoji, I. Taisuke et al. Use of saliva for monitoring unbound free cortisol levels in serum. Clin. Chim. Acta 110, 245–253 (1981)
G. Read, R. Walker, D. Wilson et al. Steroid analysis in saliva for the assessment of endocrine function. Ann. NY Acad. Sci. 595, 260–274 (1990)
B.M. Arafah, F.J. Nishiyama, H. Tlaygeh et al. Measurement of salivary cortisol concentration in the assessment of adrenal function in critically ill subjects: a surrogate marker of the circulating free cortisol. J. Clin. Endocrinol. Metab. 92, 2965–2971 (2007)
E. Cardoso, G. Persi, N. González et al. Assessment of adrenal function by measurement of salivary steroids in response to corticotrophin in patients infected with human immunodeficiency virus. Steroids 72, 328–334 (2007)
E. Aardal-Eriksson, B.E. Karlberg, A.-C. Holm, Salivary cortisol-an alternative to serum cortisol determinations in dynamic function tests. Clin. Chem. Lab Med. 36, 215–222 (1998)
N. Kamodyová, L. Baňasová, K. Janšáková, et al. Blood contamination in saliva: impact on the measurement of salivary oxidative stress markers. Dis. Markers. 2015, 479251 (2015)
T. Thevenot, S. Borot, A. Remy‐Martin et al. Assessment of adrenal function in cirrhotic patients using concentration of serum‐free and salivary cortisol. Liver Int. 31, 425–433 (2011)
K.I. Alexandraki, A.B. Grossman, Is urinary free cortisol of value in the diagnosis of Cushing’s syndrome? Curr. Opin. Endocrinol. Diabetes Obes. 18, 259–263 (2011)
G. Fede, L. Spadaro, T. Tomaselli et al. Assessment of adrenocortical reserve in stable patients with cirrhosis. J. Hepatol. 54, 243–250 (2011)
A. Galbois, M. Rudler, J. Massard et al. Assessment of adrenal function in cirrhotic patients: salivary cortisol should be preferred. J. Hepatol. 52, 839–845 (2010)
R. de Franchis, Expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension. J. Hepatol. 63, 743–752 (2015)
G. Garcia-Tsao, J.G. Abraldes, A. Berzigotti et al. Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases. Hepatology 65, 310–335 (2017)
G. Garcia-Tsao, J. Lim; Program VAHCRC, Management and treatment of patients with cirrhosis and portal hypertension: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program. Am. J. Gastroenterol. 104, 1802–1829 (2009)
J. Wiegand, T. Berg, The etiology, diagnosis and prevention of liver cirrhosis: part 1 of a series on liver cirrhosis. Dtsch. Arztebl. Int. 110, 85–91 (2013)
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J. Hepatol. 69, 406–460 (2018)
W. De Keyzer, I. Huybrechts, A.L.M. Dekkers et al. Predicting urinary creatinine excretion and its usefulness to identify incomplete 24 h urine collections. Br. J. Nutr. 108, 1118–1125 (2012)
L. Wood, D.H. Ducroq, H.L. Fraser et al. Measurement of urinary free cortisol by tandem mass spectrometry and comparison with results obtained by gas chromatography-mass spectrometry and two commercial immunoassays. Ann. Clin. Biochem. 45, 380–388 (2008)
A. Trifan, S. Chiriac, C. Stanciu, Update on adrenal insufficiency in patients with liver cirrhosis. World J. Gastroenterol. 19, 445–456 (2013)
R. Chawlani, A. Arora, P. Ranjan et al. Adrenal insufficiency predicts early mortality in patients with cirrhosis. U. Eur. Gastroenterol. J. 3, 529–538 (2015)
J. Ho, H. Al-Musalhi, M. Chapman et al. Septic shock and sepsis: a comparison of total and free plasma cortisol levels. J. Clin. Endocrinol. Metab. 91, 105–114 (2006)
J.-L. Coolens, H. Van Baelen, W. Heyns, Clinical use of unbound plasma cortisol as calculated from total cortisol and corticosteroid-binding globulin. J. Steroid Biochem. 26, 197–202 (1987)
T. Thevenot, S. Borot, A. Remy-Martin et al. Assessing adrenal function in cirrhotic patients: is there a reliable test? Gastroenterol. Clin. Biol. 33, 584–588 (2009)
N.C. Nicolaides, G.P. Chrousos, E. Charmandari, Adrenal insufficiency (2015)
L.K. Nieman, B.M. Biller, J.W. Findling et al. The diagnosis of Cushing’s syndrome: an Endocrine Society Clinical Practice Guideline. J. Clin. Endocrinol. Metab. 93, 1526–1540 (2008)
C. Jung, S. Greco, H.H. Nguyen et al. Plasma, salivary and urinary cortisol levels following physiological and stress doses of hydrocortisone in normal volunteers. BMC Endocr. Disord. 14, 91 (2014)
K.I. Alexandraki, A.B. Grossman, Is urinary free cortisol of value in the diagnosis of Cushing’s syndrome? Curr. Opin. Endocrinol. Diabetes Obes. 18, 259–263 (2011)
T. Tan, L. Chang, A. Woodward et al. Characterising adrenal function using directly measured plasma free cortisol in stable severe liver disease. J. Hepatol. 53, 841–848 (2010)
G. Fede, L. Spadaro, T. Tomaselli et al. Comparison of total cortisol, free cortisol, and surrogate markers of free cortisol in diagnosis of adrenal insufficiency in patients with stable cirrhosis. Clin. Gastroenterol. Hepatol. 12, 504–512. e508 (2014)
J. Acevedo, J. Fernández, V. Prado et al. Relative adrenal insufficiency in decompensated cirrhosis: Relationship to short-term risk of severe sepsis, hepatorenal syndrome, and death. Hepatology 58, 1757–1765 (2013)
T. Thevenot, R. Dorin, E. Monnet et al. High serum levels of free cortisol indicate severity of cirrhosis in hemodynamically stable patients. J. Gastroenterol. Hepatol. 27, 1596–1601 (2012)
P.E. Marik, Adrenal-exhaustion syndrome in patients with liver disease. Intensive Care Med. 32, 275–280 (2006)
Funding
This work has been supported by “Hellenic Association for the Study of the Liver”.
Author information
Authors and Affiliations
Contributions
M. Michailidou: acquisition of data and analysis and interpretation of data; I.A.: acquisition of data, analysis and interpretation of data, and drafting of the manuscript; M.K. and K.Z.: acquisition of data and analysis and interpretation of data; E.P.T. and K.K.: analysis and interpretation of data, statistical analysis; E.T.: analysis and interpretation of data; M. Mandellou and G.D.: acquisition of data; N.K.: analysis of data; M. Michalaki, C.G., D.V., C.K.M., and K.T.: analysis and interpretation of data, critical revision of the manuscript for important intellectual content; C.T.: study concept and design, drafting of the manuscript, critical revision of the manuscript for important intellectual content, final approval of the version to be published. We confirm that the manuscript has been read and approved by all named authors and that there are no other persons who satisfied the criteria for authorship but are not listed.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Ethical approval
All study participants, or their legal guardian, provided informed written consent prior to study enrollment. The study protocol was reviewed and approved by the Ethics committee of the University Hospital of Patras. The study protocol conformed to the ethical guidelines of the 1975 Declaration of Helsinki for medical research involving human subjects. All the experiments were performed in accordance with relevant guidelines and regulations of the concerned Ethics committee.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
About this article
Cite this article
Michailidou, M., Aggeletopoulou, I., Kouskoura, M. et al. Urinary free cortisol is a reliable index of adrenal cortisol production in patients with liver cirrhosis. Endocrine 76, 697–708 (2022). https://doi.org/10.1007/s12020-022-03055-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-022-03055-2